Neuraworx Medical Technology, a neurotechnology company developing first-in-class bioelectronic solutions for brain health originally developed at the University of Wisconsin-Madison, today announced the successful close of its oversubscribed Seed funding round led by Nexus NeuroTech Ventures, with participation from Foothill Ventures, Verge HealthTech Fund, Wisconsin Alumni Research Foundation (WARF), and other leading neurotech investors.

NeuraWorx is a clinical-stage neurotechnology company pioneering bioelectronic solutions to restore cerebrovascular and glymphatic function. Based in Excelsior, MN, the company is developing the Cerebrovascular Pacing System™, a proprietary platform designed to enhance brain fluid dynamics for the treatment of central nervous system disorders.